Predicting and managing sepsis in burn patients

Current perspectives

Omar Nunez Lopez, Janos Cambiaso-Daniel, Ludwik Branski, William Norbury, David Herndon

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Modern burn care has led to unprecedented survival rates in burn patients whose injuries were fatal a few decades ago. Along with improved survival, new challenges have emerged in the management of burn patients. Infections top the list of the most common complication after burns, and sepsis is the leading cause of death in both adult and pediatric burn patients. The diagnosis and management of sepsis in burns is complex as a tremendous hypermetabolic response secondary to burn injury can be superimposed on systemic infection, leading to organ dysfunction. The management of a septic burn patient represents a challenging scenario that is commonly encountered by providers caring for burn patients despite preventive efforts. Here, we discuss the current perspectives in the diagnosis and treatment of sepsis and septic shock in burn patients.

Original languageEnglish (US)
Pages (from-to)1107-1117
Number of pages11
JournalTherapeutics and Clinical Risk Management
Volume13
DOIs
StatePublished - Aug 29 2017

Fingerprint

Sepsis
management
Pediatrics
cause of death
Burns
scenario
Wounds and Injuries
Septic Shock
Infection
Cause of Death
Survival Rate
Survival
Therapeutics

Keywords

  • Antibiotics
  • Biomarkers
  • Burn injury
  • Burn sepsis
  • Cytokines
  • Procalcitonin
  • Thermal injury

ASJC Scopus subject areas

  • Medicine(all)
  • Safety Research
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Chemical Health and Safety
  • Pharmacology (medical)

Cite this

Predicting and managing sepsis in burn patients : Current perspectives. / Nunez Lopez, Omar; Cambiaso-Daniel, Janos; Branski, Ludwik; Norbury, William; Herndon, David.

In: Therapeutics and Clinical Risk Management, Vol. 13, 29.08.2017, p. 1107-1117.

Research output: Contribution to journalReview article

Nunez Lopez, Omar ; Cambiaso-Daniel, Janos ; Branski, Ludwik ; Norbury, William ; Herndon, David. / Predicting and managing sepsis in burn patients : Current perspectives. In: Therapeutics and Clinical Risk Management. 2017 ; Vol. 13. pp. 1107-1117.
@article{447255867a0b46fabfaa84acf28c9fe0,
title = "Predicting and managing sepsis in burn patients: Current perspectives",
abstract = "Modern burn care has led to unprecedented survival rates in burn patients whose injuries were fatal a few decades ago. Along with improved survival, new challenges have emerged in the management of burn patients. Infections top the list of the most common complication after burns, and sepsis is the leading cause of death in both adult and pediatric burn patients. The diagnosis and management of sepsis in burns is complex as a tremendous hypermetabolic response secondary to burn injury can be superimposed on systemic infection, leading to organ dysfunction. The management of a septic burn patient represents a challenging scenario that is commonly encountered by providers caring for burn patients despite preventive efforts. Here, we discuss the current perspectives in the diagnosis and treatment of sepsis and septic shock in burn patients.",
keywords = "Antibiotics, Biomarkers, Burn injury, Burn sepsis, Cytokines, Procalcitonin, Thermal injury",
author = "{Nunez Lopez}, Omar and Janos Cambiaso-Daniel and Ludwik Branski and William Norbury and David Herndon",
year = "2017",
month = "8",
day = "29",
doi = "10.2147/TCRM.S119938",
language = "English (US)",
volume = "13",
pages = "1107--1117",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Predicting and managing sepsis in burn patients

T2 - Current perspectives

AU - Nunez Lopez, Omar

AU - Cambiaso-Daniel, Janos

AU - Branski, Ludwik

AU - Norbury, William

AU - Herndon, David

PY - 2017/8/29

Y1 - 2017/8/29

N2 - Modern burn care has led to unprecedented survival rates in burn patients whose injuries were fatal a few decades ago. Along with improved survival, new challenges have emerged in the management of burn patients. Infections top the list of the most common complication after burns, and sepsis is the leading cause of death in both adult and pediatric burn patients. The diagnosis and management of sepsis in burns is complex as a tremendous hypermetabolic response secondary to burn injury can be superimposed on systemic infection, leading to organ dysfunction. The management of a septic burn patient represents a challenging scenario that is commonly encountered by providers caring for burn patients despite preventive efforts. Here, we discuss the current perspectives in the diagnosis and treatment of sepsis and septic shock in burn patients.

AB - Modern burn care has led to unprecedented survival rates in burn patients whose injuries were fatal a few decades ago. Along with improved survival, new challenges have emerged in the management of burn patients. Infections top the list of the most common complication after burns, and sepsis is the leading cause of death in both adult and pediatric burn patients. The diagnosis and management of sepsis in burns is complex as a tremendous hypermetabolic response secondary to burn injury can be superimposed on systemic infection, leading to organ dysfunction. The management of a septic burn patient represents a challenging scenario that is commonly encountered by providers caring for burn patients despite preventive efforts. Here, we discuss the current perspectives in the diagnosis and treatment of sepsis and septic shock in burn patients.

KW - Antibiotics

KW - Biomarkers

KW - Burn injury

KW - Burn sepsis

KW - Cytokines

KW - Procalcitonin

KW - Thermal injury

UR - http://www.scopus.com/inward/record.url?scp=85028649586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028649586&partnerID=8YFLogxK

U2 - 10.2147/TCRM.S119938

DO - 10.2147/TCRM.S119938

M3 - Review article

VL - 13

SP - 1107

EP - 1117

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

ER -